Skip to content
Open access

The inhibitory effect of gadolinium-conjugated diflunisal on platelet function through regulating outside-in signaling of αIIbβ3 integrin

Oct 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 43 references
Medicine

TL;DR

Findings demonstrate that ETN102 is a thrombin-context selective modulator of platelet integrin αIIbβ3 outside-in signaling, with antithrombotic and neuroprotective potential.

Abstract

The gadolinium-conjugated diflunisal derivative ETN102 has previously been shown to suppress cyclooxygenase-2 (COX-2) levels, reduce glial activation, and attenuate neuronal damage associated with stroke. In the present study, we investigated whether ETN102 modulates platelet aggregation and activation. ETN102 selectively inhibited thrombin-induced platelet aggregation while sparing platelet responses to other agonists, including collagen, adenosine diphosphate (ADP), and U46619. ETN102 also reduced adenosine triphosphate (ATP) secretion under aggregating conditions without altering thromboxane B2 (TXB2) generation, suggesting that its antiplatelet effect is independent of the COX-1-dependent thromboxane signaling. Flow cytometric and biochemical analyses further demonstrated that ETN102 suppressed thrombin-induced αIIbβ3 integrin activation, platelet spreading, clot retraction, and the phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), without affecting granule secretion, intracellular Ca2+ mobilization, or phosphorylation of Syk, PI3K, and AKT signaling molecules. In vivo, ETN102 significantly prolonged carotid artery occlusion time in a ferric chloride (FeCl3)-induced thrombosis model and increased tail bleeding time and hemoglobin content. In addition, ETN102 reduced infarct volume and improved neuronal survival markers in a murine model of cerebral ischemia/reperfusion injury. These findings demonstrate that ETN102 is a thrombin-context selective modulator of platelet integrin αIIbβ3 outside-in signaling, with antithrombotic and neuroprotective potential.

Read PDF

Similar papers

Oct 2026

Schisandrin B attenuates the platelet activation-thrombosis cascade through inhibition of Phosphatidylinositol 3-kinase/AKT and Extracellular signal-regulated kinase-Talin-mediated integrin αIIbβ3 signaling.

ETHNOPHARMACOLOGICAL RELEVANCE Schisandrin B (Sch B), a principal bioactive lignan derived from Schisandra chinensis (Turcz.) Baill. exhibits diverse pharmacological activities. This traditional Chinese medicine possesses therapeutic value for treating symptoms such as palpitations, shortness of breath, and a faint, ne...

Meng-Yao Li, Zi-Xian Liu, Yue-Yue Shen et al. · 0 citations
Open access Sep 2026

Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis

Picropodophyllotoxin (PPT), a naturally occurring tyrosine kinase inhibitor derived from Podophyllum hexandrum roots, is well recognized for its anticancer potential. The present study was designed to determine whether PPT exerts antithrombotic effects and to elucidate the underlying mechanisms. A range of functional a...

Gyuri Han, G. Kim, Min Seo Kim et al. · 0 citations
Nov 2026

Abstract 10195: Comparing the Antiplatelet and Antithrombotic Effects of CCG263719 and SLUG001, Second Generation 12-Lipoxygenase Inhibitors, to ML355

Background: Platelet-mediated thrombosis is a major contributor to myocardial infarction and other cardiovascular diseases. Reperfusion following ischemia can further exacerbate tissue injury, in part through platelet activation and inflammatory signaling. Platelet 12(S)-lipoxygenase (12-LOX), an oxygenase that prom...

Krista A. Goerger, Prisha Mehta, M. Flores et al. · 0 citations
Open access Oct 2026

PO090 | INCOMPLETE THROMBIN INHIBITION: BIOCHEMICAL AND FUNCTIONAL EVIDENCE OF ADP P2Y1 RECEPTOR DESENSITIZATION IN HUMAN PLATELETS

Background and Aims. Adenosine diphosphate (ADP) is a key agonist of platelet activation and aggregation through the stimulation of purinergic receptors P2Y₁ and P2Y₁₂. Tight regulation of ADP-mediated signaling is essential during platelet plug formation. It has recently been demonstrated that the P2Y₁ receptor, upon...

E. Schiera · 0 citations
Oct 2026

Dietary Flavonoid Phloretin and Its Synthetic Derivative Inhibit Platelet Activation and Thrombosis via the SRC/PI3K/Akt Signaling Pathway.

Thrombotic diseases are a leading cause of global mortality, primarily driven by pathological platelet activation. Phloretin, a natural flavonoid abundant in apple peels with anti-inflammatory and antioxidant properties, is limited by poor solubility and bioavailability. To overcome these limitations, a synthetic deriv...

Gang Liu, K. Wen, Shan-Hui Zhang et al. · 0 citations
Oct 2026

Inhibition of mitochondrial permeability transition selectively suppresses thrombogenic platelet procoagulant activity.

Platelets support coagulation by externalizing phosphatidylserine (PS), creating a catalytic surface for thrombin generation and fibrin formation. Although platelet PS exposure is required for hemostasis, excessive procoagulant platelet activity drives thrombosis. Sustained calcium influx after strong agonist stimulati...

Yi-Heng Zhang, Jordan Sandler, O. Owegie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.